FBL promotes cancer cell resistance to DNA damage and BRCA1 transcription via YBX1.
Xiaorui SunCongwen GaoXin XuMengyuan LiXinhua ZhaoYanan WangYun WangShun ZhangZhenzhen YanXiuhua LiuChen WuPublished in: EMBO reports (2023)
Fibrillarin (FBL) is a highly conserved nucleolar methyltransferase responsible for methylation of ribosomal RNA and proteins. Here, we reveal a role for FBL in DNA damage response and its impact on cancer proliferation and sensitivity to DNA-damaging agents. FBL is highly expressed in various cancers and correlates with poor survival outcomes in cancer patients. Knockdown of FBL sensitizes tumor cells and xenografts to DNA crosslinking agents, and leads to homologous recombination-mediated DNA repair defects. We identify Y-box-binding protein-1 (YBX1) as a key interacting partner of FBL, and FBL increases the nuclear accumulation of YBX1 in response to DNA damage. We show that FBL promotes the expression of BRCA1 by increasing the binding of YBX1 to the BRCA1 promoter. Our study sheds light on the regulatory mechanism of FBL in tumorigenesis and DNA damage response, providing potential therapeutic targets to overcome chemoresistance in cancer.
Keyphrases
- dna repair
- dna damage response
- dna damage
- binding protein
- transcription factor
- papillary thyroid
- oxidative stress
- circulating tumor
- dna methylation
- squamous cell
- genome wide
- poor prognosis
- cell free
- gene expression
- signaling pathway
- single molecule
- childhood cancer
- breast cancer risk
- dna binding
- nucleic acid
- single cell
- long non coding rna
- human immunodeficiency virus
- hepatitis c virus
- risk assessment
- protein kinase